ArticleFrontiers in medicine2026
Clinical effects of integrated Chinese medicine therapy for postpartum pelvic floor dysfunction: a prospective patient-preference cohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the therapeutic efficacy of Dabu-Yuanjian Tisheng formula combined with acupoint stimulation for postpartum pelvic floor dysfunction (PFD) compared with single-modality and standard rehabilitation. Methods: This prospective, patient-preference observational study enrolled 212 postpartum women diagnosed with PFD, who chose one of four management options after standardized counseling. Group A received Dabu-Yuanjian Tisheng formula alone, Group B acupoint stimulation alone, Group C the combined therapy, and Group D standard electrical stimulation with biofeedback. Quota sampling targeted 53 participants per group. The 8-week intervention evaluated changes in POP-Q staging, urinary incontinence symptoms (ICIQ-SF), vaginal dynamic pressure, and traditional Chinese medicine (TCM) syndrome scores; pelvic floor muscle strength (Modified Oxford Scale) was assessed to characterize severity. Between-group comparisons used ANCOVA for continuous variables and proportional-odds models for ordinal outcomes, adjusted for prespecified covariates and baseline values. Missing data were handled via multiple imputation. Results: A total of 212 participants (53 per group) were analyzed. Baseline characteristics were generally comparable. All groups showed significant pre- to post-treatment improvement across major outcomes (all Conclusion: In this patient-preference cohort, the choice of Dabu-Yuanjian Tisheng formula combined with acupoint stimulation was associated with greater improvements in postpartum PFD outcomes compared to single-modality or standard rehabilitation. However, because treatment allocation was non-randomized and residual confounding cannot be excluded, these findings should be interpreted as supportive comparative evidence rather than definitive proof of superiority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.